Brian K. Adler

Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia

Martin H. Steinberg, Franca B. Barton, Oswaldo Castro et al. · JAMA · 2003 · 899 citations · Full text

Medicine, Hematology, Pharmacotherapy +9

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

Mutay Aslan, Thomas M. Ryan, Brian K. Adler et al. · Proceedings of the National Academy of Sciences · 2001 · 385 citations · Full text

Life Sciences, Biochemistry, Physiology +17

Purified Poloxamer 188 for Treatment of Acute Vaso-occlusive Crisis of Sickle Cell Disease

Eugene P. Orringer, James F. Casella, Kenneth I. Ataga et al. · JAMA · 2001 · 197 citations

Medicine, Hematology, Pharmacotherapy +13

Influence of <i>CYP2C9</i> and <i>VKORC1</i> on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–Americans

Nita A. Limdi, Donna K. Arnett, Joyce A. Goldstein et al. · Pharmacogenomics · 2008 · 160 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers.

R M Zinkernagel, Alana Althage, Brian K. Adler et al. · The Journal of Experimental Medicine · 1977 · 126 citations · Full text

Life Sciences, Immunology, Microbiology +16